Enzalutamide in European and North American men participating in the AFFIRM trial

OBJECTIVE: To explore any differences in efficacy and safety outcomes between European (EU) (n = 684) and North American (NA) (n = 395) patients in the AFFIRM trial (NCT00974311). PATIENTS AND METHODS: Phase III, double-blind, placebo-controlled, multinational AFFIRM trial in men with metastatic cas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BJU Int
Main Authors: Merseburger, Axel S, Scher, Howard I, Bellmunt, Joaquim, Miller, Kurt, Mulders, Peter FA, Stenzl, Arnulf, Sternberg, Cora N, Fizazi, Karim, Hirmand, Mohammad, Franks, Billy, Haas, Gabriel P, de Bono, Johann, de Wit, Ronald
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Ltd 2015
Assuntos:
Urological Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4312486/
https://ncbi.nlm.nih.gov/pubmed/25123978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.12898
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados